EndothelinB receptor blocker inhibits high glucose-induced synthesis of fibronectin in human peritoneal mesothelial cells

Peritoneal Dialysis International

Volumn 26, Issue 3, 2006, Pages 393-401

  Shimizu, Miyuki ^a,b   Ishibashi, Yoshitaka ^a   Taki, Fumika ^a   Shimizu, Hideki ^a   Hirahara, Ichiro ^a,b   Kaname, Shinya ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TERUMO CORPORATION   (Japan)

Author keywords

Endothelin; Endothelin receptor antagonist; Fibronectin; High glucose; Human peritoneal mesothelial cell; Peritoneal fibrosis; Reactive oxygen species

Indexed keywords

5 CHLOROMETHYL 2',7' DICHLORODIHYDROFLUORESCEIN DIACETATE ACETYL ESTER; 6 CHLOROMETHYL 2',7' DICHLORODIHYDROFLUORESCEIN DIACETATE ACETYL ESTER; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIALYSIS FLUID; DIPHENYLENEIODIUM CHLORIDE; DIPHENYLIODONIUM SALT; DYE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; FIBRONECTIN; GLUCOSE; LEVO GLUCOSE; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; REACTIVE OXYGEN METABOLITE; TEMPOL; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; FIBROSIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; MESOTHELIUM CELL; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33748413338     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600318     Document Type: Article

References (29)

1. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
2. Majorca R, Oreopoulos DG. The peritoneum during peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 3):S37-63.
3. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-41.
4. Sheetz MJ, King GL. Molecular understanding of hyper-glycemia's adverse effects for diabetic complications. JAMA 2002; 288:2579-88.
5. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283:1483-8.
6. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004; 65:1170-9.
7. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59:463-70.
8. B receptor blockade of human peritoneal mesothelial cells inhibits collagen I RNA synthesis. Kidney Int 2003; 64:2033-40.
9. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
10. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 1988; 85: 6964-7.
11. Masaki T. The discovery of endothelins. Cardiovasc Res 1998; 39:530-3.
12. Thomas FL, Matthias B. Endothelins and endothelin receptor antagonists. Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000; 102: 2434-40.
13. Ito H. Endothelins and cardiac hypertrophy. Life Sci 1997; 61:585-93.
14. Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 2003; 285:F579-F589.
15. Rochy DC, Chung JJ. Endothelin antagonism in experimental hepatic fibrosis. J Clin Invest 1996; 98:1381-8.
16. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: agraded response to membrane stimulation. J Immunol 1983; 130:1910-17.
17. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
18. Ishibashi Y, Sugimoto T, Ichikawa Y, Akatsuka A, Miyata T, Nangaku M, et al. Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells. Perit Dial Int 2002; 22:11-21.
19. B receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 2005; 145:323-33.
20. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1. Am J Physiol Cell Physiol 2003; 284:C263-C272.
21. Yang T, Terada Y, Nonoguchi H, Ujiie K, Tomita K, Marumo F. Effect of hyperosmolality on production and mRNA expression of ET-1 in inner medullary collecting duct. Am J Physiol 1993; 264:F684-F689.
22. Schramek H, Gstraunthaler G, Willinger CC, Phaller W. Hyperosmolality regulates endothelin release by Madin-Darby canine kidney cells. J Am Soc Nephrol 1993; 4:206-13.
23. Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 2000; 58:1534-45.
24. Morgera S, Kuchinke S, Budde K, Lun A, Hocher B, Neumayer HH. Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1999; 10:2585-90.
25. Chen S, Apostolova MD, Cherian MG, Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeabilityin endothelial cells. Lab Invest 2000; 80:1311-21.
26. Kiribayashi K, Masaki T, Naito T, Ogawa T, Ito T, Yorioka N, et al. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int 2005; 67:1126-35.
27. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33:306-10.
28. Lerman A, Hildebrand FL, Aarhus LL, Burnett JC. Endothelin has biological actions at physiological concentrations. Circulation 1991; 83:1808-14.
29. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004; 22:1141-9.